“Imperfect vaccines and the evolution of pathogen virulence.”

Abstract: …”Here we show that vaccines designed to reduce pathogen growth rate and/or toxicity diminish selection against virulent pathogens. The subsequent evolution leads to higher levels of intrinsic virulence and hence to more severe disease in unvaccinated individuals. This evolution can erode any population-wide benefits such that overall mortality rates are unaffected, or even increase, with the level of vaccination coverage. These findings have policy implications for the development and use of vaccines that are not expected to provide full immunity, such as candidate vaccines for malaria.”

~S Gandon  1 , M J Mackinnon, S Nee, A F Read, Institute of Cell, Animal and Population Biology, The University of Edinburgh, Edinburgh EH9 3JT, UK.

Nature.2001 Dec 13;414(6865):751-6. doi: 10.1038/414751a.

In other words, the medical and scientific community and the world have known for 20 years that vaccines which only treat symptoms without terminating the virus result in more infectious and dangerous disease and higher overall deaths. This is the Antibody-Dependent Enhancement (ADE) and immune escape described by brave doctors and scientists who are being blocked by social and mainstream media and ignored by governments and others with sworn duty to protect public health.

https://pubmed.ncbi.nlm.nih.gov/11742400/

#research #science #disease #health #publichealth #medicine #children #media #university #covid19pandemic #covid19news #covidresponse #pandemic2021 #sarscov2 #vaccine

About budbromley

Bud is a retired life sciences executive. Bud's entrepreneurial leadership exceeded three decades. He was the senior business development, marketing and sales executive at four public corporations, each company a supplier of analytical and life sciences instrumentation, software, consumables and service. Prior to those positions, his 19 year career in Hewlett-Packard Company's Analytical Products Group included worldwide sales and marketing responsibility for Bioscience Products, Global Accounts and the International Olympic Committee, as well as international management assignments based in Japan and Latin America. Bud has visited and worked in more than 65 countries and lived and worked in 3 countries.
This entry was posted in Uncategorized. Bookmark the permalink.

Leave a Reply

Please log in using one of these methods to post your comment:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.